Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | peroxisome proliferator-activated receptor gamma | Starlite/ChEMBL | References |
Homo sapiens | peroxisome proliferator-activated receptor alpha | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | nuclear hormone receptor superfamily protein-related | Get druggable targets OG5_137778 | All targets in OG5_137778 |
Schistosoma japonicum | IPR008946,Nuclear receptor, ligand-binding,domain-containing | Get druggable targets OG5_137778 | All targets in OG5_137778 |
Schistosoma japonicum | ko:K08701 nuclear receptor, subfamily 1, invertebrate, putative | Get druggable targets OG5_137778 | All targets in OG5_137778 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | ecdysteroid receptor | peroxisome proliferator-activated receptor alpha | 468 aa | 397 aa | 25.4 % |
Echinococcus granulosus | ecdysone induced protein 78C | peroxisome proliferator-activated receptor gamma | 477 aa | 447 aa | 28.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Loa Loa (eye worm) | trypsin family protein | 0.0233 | 0.0803 | 0.0816 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0472 | 0.2087 | 1 |
Brugia malayi | Trypsin family protein | 0.1911 | 0.9833 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1911 | 0.9833 | 1 |
Onchocerca volvulus | 0.0233 | 0.0803 | 0.0816 | |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Mycobacterium ulcerans | hypothetical protein | 0.0233 | 0.0803 | 0.5 |
Onchocerca volvulus | 0.0233 | 0.0803 | 0.0816 | |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Brugia malayi | Trypsin-like protease protein 5 | 0.0233 | 0.0803 | 0.0816 |
Schistosoma mansoni | nuclear hormone receptor superfamily protein-related | 0.0427 | 0.1843 | 0.1843 |
Leishmania major | hypothetical protein, conserved | 0.0472 | 0.2087 | 0.5 |
Brugia malayi | Muscle positioning protein 4 | 0.0113 | 0.0157 | 0.016 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | hypothetical protein | 0.0472 | 0.2087 | 0.2087 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0104 | 0.0108 | 0.0108 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1911 | 0.9833 | 0.9833 |
Loa Loa (eye worm) | hypothetical protein | 0.0472 | 0.2087 | 0.2123 |
Onchocerca volvulus | 0.1678 | 0.8577 | 0.8722 | |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0472 | 0.2087 | 0.2123 |
Loa Loa (eye worm) | hypothetical protein | 0.1911 | 0.9833 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0472 | 0.2087 | 0.2123 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0472 | 0.2087 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.0157 | 0.016 |
Brugia malayi | Trypsin family protein | 0.0233 | 0.0803 | 0.0816 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Toxoplasma gondii | PAN domain-containing protein | 0.1177 | 0.5882 | 1 |
Brugia malayi | Trypsin family protein | 0.0233 | 0.0803 | 0.0816 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Brugia malayi | Kringle domain containing protein | 0.0472 | 0.2087 | 0.2123 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0472 | 0.2087 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Brugia malayi | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Onchocerca volvulus | 0.0472 | 0.2087 | 0.2123 | |
Brugia malayi | Trypsin family protein | 0.0233 | 0.0803 | 0.0816 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Onchocerca volvulus | 0.1911 | 0.9833 | 1 | |
Toxoplasma gondii | PAN domain-containing protein | 0.1177 | 0.5882 | 1 |
Onchocerca volvulus | 0.0233 | 0.0803 | 0.0816 | |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0249 | 0.0887 | 0.0887 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Schistosoma mansoni | aminopeptidase PILS (M01 family) | 0.0233 | 0.0803 | 0.0803 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.0233 | 0.0803 | 0.0816 |
Onchocerca volvulus | 0.0113 | 0.0157 | 0.016 | |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0472 | 0.2087 | 0.5 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0233 | 0.0803 | 0.0803 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0472 | 0.2087 | 0.5 |
Onchocerca volvulus | 0.0233 | 0.0803 | 0.0816 | |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.0803 | 0.0816 |
Onchocerca volvulus | 0.0233 | 0.0803 | 0.0816 | |
Schistosoma mansoni | hypothetical protein | 0.0233 | 0.0803 | 0.0803 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
%max (functional) | = 95 % | Agonist activity at human PPAR gamma in a HepG2 cells by PPAR-GAL4 transactivation assay relative to darglitazone | ChEMBL. | 16973358 |
%max (functional) | = 95 % | Agonist activity at human PPAR gamma in a HepG2 cells by PPAR-GAL4 transactivation assay relative to darglitazone | ChEMBL. | 16973358 |
%max (functional) | = 100 % | Agonist activity at human PPAR alpha in a HepG2 cells by PPAR-GAL4 transactivation assay relative to GW2331 | ChEMBL. | 16973358 |
%max (functional) | = 100 % | Agonist activity at human PPAR alpha in a HepG2 cells by PPAR-GAL4 transactivation assay relative to GW2331 | ChEMBL. | 16973358 |
EC50 (binding) | = 0.013 uM | Displacement of radiolabeled GW2331 from human PPAR alpha by SPA binding assay | ChEMBL. | 16973358 |
EC50 (binding) | = 0.013 uM | Displacement of radiolabeled GW2331 from human PPAR alpha by SPA binding assay | ChEMBL. | 16973358 |
EC50 (functional) | = 0.05 uM | Agonist activity at human PPAR gamma in a HepG2 cells by PPAR-GAL4 transactivation assay | ChEMBL. | 16973358 |
EC50 (functional) | = 0.05 uM | Agonist activity at human PPAR gamma in a HepG2 cells by PPAR-GAL4 transactivation assay | ChEMBL. | 16973358 |
EC50 (functional) | = 0.133 uM | Agonist activity at human PPAR alpha in a HepG2 cells by PPAR-GAL4 transactivation assay | ChEMBL. | 16973358 |
EC50 (functional) | = 0.133 uM | Agonist activity at human PPAR alpha in a HepG2 cells by PPAR-GAL4 transactivation assay | ChEMBL. | 16973358 |
Ki (binding) | = 0.015 uM | Displacement of radiolabeled darglitazone from human PPAR gamma by SPA binding assay | ChEMBL. | 16973358 |
Ki (binding) | = 0.015 uM | Displacement of radiolabeled darglitazone from human PPAR gamma by SPA binding assay | ChEMBL. | 16973358 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.